11/4/2009

The PATH Malaria Vaccine Initiative has teamed up with Sanaria to develop an experimental malaria vaccine that will use a weakened form of the Plasmodium falciparum parasite. The vaccine currently is in human trials in the U.S. Other vaccine approaches being considered by the researchers include preventing the transmission of the disease from mosquitoes to humans.

Full Story:
Thaindian News

Related Summaries